Adjuvant Treatment With Polyadenylic-Polyuridylic Acid in Operable Breast Cancer: Updated Results of a Randomised Trial.

BMJ
doi 10.1136/bmj.288.6417.589
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Oral Bisphosphonates as Adjuvant Therapy for Operable Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2006English

Results of Breast Conservation Surgery in Operable Breast Cancer- Our Experience

Journal of Evidence Based Medicine and Healthcare
2017English

Breast-Cancer Adjuvant Therapy With Zoledronic Acid

New England Journal of Medicine
Medicine
2012English

Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

New England Journal of Medicine
Medicine
2005English

A Randomised Controlled Trial of Support Group Intervention After Breast Cancer Treatment: Results on Anxiety and Depression

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2011English

Efficacy and Safety of CT-P6 Versus Reference Trastuzumab in HER2-positive Early Breast Cancer: Updated Results of a Randomised Phase 3 Trial

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2019English

Adjuvant Bisphosphonates in Breast Cancer Treatment

Breast Care
SurgeryOncology
2014English

Taxanes in Adjuvant Breast Cancer Treatment

Libri Oncologici
Oncology
2018English

Adjuvant Bisphosphonate Treatment in Early Breast Cancer: Meta-Analyses of Individual Patient Data From Randomised Trials

The Lancet
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy